Predict your next investment

Life Biosciences company logo
Corporation
HEALTHCARE | Biotechnology
lifebiosciences.com

See what CB Insights has to offer

Founded Year

2016

Stage

Grant | Alive

Total Raised

$123.37M

About Life Biosciences

Life Biosciences is a longevity-focused biotechnology company that addresses the eight pathways of age-related decline (ARD).

Life Biosciences Headquarter Location

75 Park Plaza Level Three

Boston, Massachusetts, 02116,

United States

Latest Life Biosciences News

09:00 ET Life Biosciences Receives Translational Research Funding From Alzheimer's Drug Discovery Foundation

Sep 28, 2021

News provided by Share this article Share this article BOSTON, Sept. 28, 2021 /PRNewswire/ -- Life Biosciences, a pioneering life sciences company developing therapeutics that target the biology of aging, today announced translational research funding from the Alzheimer's Drug Discovery Foundation (ADDF) to support the development of chaperone-mediated autophagy (CMA) activators for the treatment of Alzheimer's disease and other neurodegenerative diseases. Chaperone-mediated autophagy removes unwanted soluble proteins from cells. CMA activity declines with age due in part to decreased expression of LAMP2A, a key protein regulating CMA activity. The age-related decline of CMA leads to an accumulation of insoluble proteins that disrupt cellular function in age-related diseases such as Alzheimer's disease. In groundbreaking work published in the peer-reviewed journal Cell in April 2021, Professor at the Albert Einstein College of Medicine and Life Biosciences founder scientist Ana Maria Cuervo, MD, PhD demonstrated the benefit of the CMA-activator platform in two mouse models of Alzheimer's disease. In both models, oral doses of CMA-activator compounds led to improvements in memory, depression, and anxiety. Life Biosciences has an exclusive license from Albert Einstein College of Medicine for this underlying technology and will continue this research by evaluating CMA-activator compounds for key early attributes needed in Alzheimer's disease drug development. "We are pleased to have received this translational research funding from the ADDF, which further validates the potential of our CMA platform to treat devastating diseases such as Alzheimer's," said Jerry McLaughlin, Chief Executive Officer of Life Biosciences. "Our preclinical work to date has demonstrated that CMA activation may be a viable therapeutic strategy in halting the progression of age-related neurodegenerative disorders and ultimately increase healthy human lifespan. We look forward to advancing this platform towards the clinic with the support of the ADDF." "Life Biosciences' innovative pathway holds exciting promise for the potential treatment and prevention of Alzheimer's disease," said Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF. "After substantial scientific review, we believe that CMA could offer a unique approach to Alzheimer's disease, and we look forward to partnering with Life Biosciences as it advances its important research towards the clinic." About Life Biosciences Life Biosciences is a private biotechnology company dedicated to developing novel therapies to extend healthy human lifespan. The Company is focusing on three platforms targeting key mechanisms underlying aging biology: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Therapies developed within each platform have the potential to prevent, treat, and/or reverse multiple aging-related diseases. For more information, please visit www.lifebiosciences.com . About the Alzheimer's Drug Discovery Foundation Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. The ADDF is the only public charity solely focused on funding the development of drugs for Alzheimer's and related dementias, employing a venture philanthropy model to support research in academia and the biotech industry. Through the generosity of its donors, the ADDF has awarded more than $168 million to fund over 650 Alzheimer's drug discovery and biomarker programs and clinical trials in 19 countries. To learn more, please visit: http://www.alzdiscovery.org/ . Media Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Life Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Life Biosciences is included in 2 Expert Collections, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

A

Advanced Materials

1,216 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

Life Biosciences Patents

Life Biosciences has filed 5 patents.

The 3 most popular patent topics include:

  • Fertility
  • Fertility medicine
  • Pennsylvania counties
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/3/2019

5/19/2020

Metabolism, Transcription factors, Cellular respiration, Pyridines, Cell biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/3/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

5/19/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Metabolism, Transcription factors, Cellular respiration, Pyridines, Cell biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Life Biosciences Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Life Biosciences Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.